Corticosteroid
Fluocinonide
The FDA lists this product in 39 strengths and forms.
Indications
Fluocinonide topical solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Contraindications
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse reactions
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Hypertrichosis Maceration of the skin Itching Acneiform eruptions Secondary infection Irritation Hypopigmentation Skin atrophy Dryness Perioral dermatitis Striae Folliculitis Allergic contact dermatitis Miliaria
Composition
- Active ingredients
- FLUOCINONIDE 0.05%
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- FLUOCINONIDE 0.1% · CreamANDA200734-001 · Prescription
- FLUOCINONIDE 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CreamNDA019117-001 · Discontinued
- FLUOCINONIDE 0.05% · GelANDA209030-001 · Prescription
- FLUOCINONIDE 0.05% · CreamANDA072488-001 · Prescription